BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27606793)

  • 1. Modern drug delivery strategies applied to natural active compounds.
    Puglia C; Lauro MR; Tirendi GG; Fassari GE; Carbone C; Bonina F; Puglisi G
    Expert Opin Drug Deliv; 2017 Jun; 14(6):755-768. PubMed ID: 27606793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications.
    Puglia C; Pignatello R; Fuochi V; Furneri PM; Lauro MR; Santonocito D; Cortesi R; Esposito E
    Curr Med Chem; 2019; 26(24):4681-4696. PubMed ID: 31203795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade.
    Melim C; Magalhães M; Santos AC; Campos EJ; Cabral C
    Expert Opin Drug Deliv; 2022 Feb; 19(2):179-197. PubMed ID: 35166619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
    Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
    Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
    Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability: issues and solutions via nanoformulations.
    Pathak K; Raghuvanshi S
    Clin Pharmacokinet; 2015 Apr; 54(4):325-57. PubMed ID: 25666353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoemulsion as Oral Drug Delivery - A Review.
    Sabjan KB; Munawar SM; Rajendiran D; Vinoji SK; Kasinathan K
    Curr Drug Res Rev; 2020; 12(1):4-15. PubMed ID: 31774040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).
    Rehman FU; Shah KU; Shah SU; Khan IU; Khan GM; Khan A
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1325-1340. PubMed ID: 27485144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability enhancers of herbal origin: an overview.
    Kesarwani K; Gupta R; Mukerjee A
    Asian Pac J Trop Biomed; 2013 Apr; 3(4):253-66. PubMed ID: 23620848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Amorphous Nanoparticles.
    Jog R; Burgess DJ
    J Pharm Sci; 2017 Jan; 106(1):39-65. PubMed ID: 27816266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers: A Successful Tool to Increase Solubility, Stability and Optimise Bioefficacy of Natural Constituents.
    Bilia AR; Piazzini V; Risaliti L; Vanti G; Casamonti M; Wang M; Bergonzi MC
    Curr Med Chem; 2019; 26(24):4631-4656. PubMed ID: 30381065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
    Shahbazi MA; Santos HA
    Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnological breakthroughs in the development of topical phytocompounds-based formulations.
    Santos AC; Rodrigues D; Sequeira JAD; Pereira I; Simões A; Costa D; Peixoto D; Costa G; Veiga F
    Int J Pharm; 2019 Dec; 572():118787. PubMed ID: 31678376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.